InsiderSource
MRNA

Moderna, Inc.

SEC CIK 1682852
$49.91 +16.7% · 90 days
90-day buys
$0
0 open-market
90-day sells
$3.45M
4 open-market
Net insider flow
−$3.45M
Net selling
Filings shown
293
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at MRNA have sold a net $3.45M of stock (0 open-market buys vs 4 sells).

Largest recent trade: Flagship Ventures Fund Iv General Partner Llc sold $25.25M of MRNA, trimming their stake 2%.

Most active filer: Afeyan Noubar, with 161 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for MRNA, newest first
View on SEC EDGAR ↗
MRNA
Moderna, Inc.
Sell Klinger Shannon Thyme · Chief Legal Officer · Open-market sale · filed 1w ago ΔOwn −4.9%

Klinger Shannon Thyme sold $173.6K of MRNA, trimming their stake 5%.

−$173.6K
3,471 sh @ $50
Advertisement
MRNA
Moderna, Inc.
Option exercise AFEYAN NOUBAR · Director · Option exercise · filed 3w ago ΔOwn +236%
+$177.4K
9,263 sh @ $19
MRNA
Moderna, Inc.
Sell AFEYAN NOUBAR · Director · Open-market sale · filed 3w ago ΔOwn −70%

Afeyan Noubar sold $433.9K of MRNA, trimming their stake 70%.

−$433.9K
9,263 sh @ $47
MRNA
Moderna, Inc.
Option exercise Hoge Stephen · President · Option exercise · filed 4w ago ΔOwn +2.5%
+$712.9K
37,226 sh @ $19
MRNA
Moderna, Inc.
Option exercise Hoge Stephen · President · Option exercise · filed 4w ago ΔOwn +1.1%
+$308.5K
16,110 sh @ $19
MRNA
Moderna, Inc.
Sell Hoge Stephen · President · Open-market sale · filed 4w ago ΔOwn −3.5%

Hoge Stephen sold $2.58M of MRNA, trimming their stake 3%.

−$2.58M
53,336 sh @ $48
MRNA
Moderna, Inc.
Sell Hussain Abbas · Director · Open-market sale · filed May 4, 2026 ΔOwn −32%

Hussain Abbas sold $265K of MRNA, trimming their stake 32%.

−$265K
5,682 sh @ $47
MRNA
Moderna, Inc.
Option exercise Mock James M · Chief Financial Officer · Option exercise · filed Apr 6, 2026 ΔOwn +2.5%
+$0
1,453 sh
MRNA
Moderna, Inc.
Tax withholding Mock James M · Chief Financial Officer · Tax withholding · filed Apr 6, 2026 ΔOwn −1.2%
−$35.2K
703 sh @ $50
MRNA
Moderna, Inc.
Option exercise Mock James M · Chief Financial Officer · Option exercise · filed Mar 6, 2026 ΔOwn +23%
+$0
11,797 sh
MRNA
Moderna, Inc.
Tax withholding Mock James M · Chief Financial Officer · Tax withholding · filed Mar 6, 2026 ΔOwn −9.1%
−$329.7K
5,704 sh @ $58
MRNA
Moderna, Inc.
Sell Klinger Shannon Thyme · Chief Legal Officer · Open-market sale · filed Mar 3, 2026 ΔOwn −19%

Klinger Shannon Thyme sold $726K of MRNA, trimming their stake 19%.

−$726K
13,885 sh @ $52
MRNA
Moderna, Inc.
Option exercise Hoge Stephen · President · Option exercise · filed Mar 3, 2026 ΔOwn +2.5%
+$0
37,131 sh
Advertisement

About MRNA insider activity

This page tracks every recent Form 4 filed for Moderna, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is MRNA insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Moderna, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.